content top

The EVRS Macular Edema Study Results

http://www.dailymotion.com/video/xudvm0

Read More

The Effectiveness and Safety of Triamcinolone Injections in DME

http://www.dailymotion.com/video/xudsd8 http://www.dailymotion.com/video/xuf2lx Advantages: Intravitreal triamcinolone injections turned out to be effective in reducing macular edema and improving vision in refractory DME after a laser treatment or even as an initial treatment. The steroid-related adverse events, e.g. cataract and elevated intraocular pressure, should be weighed against the benefits of the treatment. Methods: Twenty-mg...

Read More

Effectivity of Intravitreal Triamcinolone Injections for Diabetic Cystoid Macular Edema

http://www.dailymotion.com/video/xudsd8 http://www.dailymotion.com/video/xuf2lx Persistent diffuse macular edema (ME) or cystoid ME is a result of chronic inflammation with the generalized breakdown of the inner blood retinal barrier and fluid accumulation, primarily in the outer plexiform layer. This process is characterized by the development of hard exudates and progressively lost of vision. Triamcinolone acetonide is the most effective...

Read More

Comparison of Endovitreal Triamcinolone with Betamethasone in DME

http://www.dailymotion.com/video/xudsd8 http://www.dailymotion.com/video/xuf2lx Advantages: Use of intravitreal injection of crystalline corticosteroids- bethamethasone and triamcinole dose of 4 mg in 0.1 ml allows to improve visual acuity and restore adequate morphological retinal thickness in patients with diffuse diabetic macular edema. Methods: Comparison of efficacy and safety of intravitreal injection of 4 mg (0.1 mL) triamcinolon...

Read More

Fluocinolone Acetonide Implants for the Treatment of Chronic DME

http://www.dailymotion.com/video/xudsd8 http://www.dailymotion.com/video/xuf2lx Advantages: Given the chronic nature of diabetic macular edema (DME), an implant (ILUVIEN®) that releases a continuous, submicrogram daily dose of fluocinolone acetonide (FAc) could fill an unmet need for continuous long-term therapy. Methods: The Fluocinolone Acetonide in Diabetic Macular Edema (FAME) study consisted of 2 randomized, prospective, multicenter,...

Read More

Micropulse Contiguous Grid Laser for Resistant Diffuse DME

http://www.dailymotion.com/video/xueopo Purpose: To investigate micropulse contiguous grid laser (MCGL) for DDME involving the fovea, and to correlate OCT findings with resolution target visual fields (RTVF) scotomas and global macular acuity (GMA). Methods: One year retrospective review of sequentially treated eyes including, OCT, FA, RTVF and NEI-VFQ 25. Results: In 56 eyes GMA improved 0.2 logMAR in 34%, with none worsening >0.3...

Read More

Effectiveness of Combined Betamethasone and Laser Coagulation for DME

http://www.dailymotion.com/video/xueopo Advantages: Combined treatment of diffuse diabetic macular edema using intravitreal injection of bethamethasone and laser coagulation is effective in improving visual acuity and restoration of the morphofunctional state of the retina. Methods: Intravitreal injection 4 mg (0.1 ml) of bethamethasone combined with laser coagulation was conducted in 33 patients (33 eyes) with diffused diabetic macular...

Read More

Micropulse Laser Following Intra Vitreal Bevacizumab in Diffuse DME

http://www.dailymotion.com/video/xueopo Advantages: Intravitreal bevacizumab followed by laser micropulse in CSME offers a clear advantage of non-inducing a visible retinal burn and having a potential efficiency in reducing foveal thickness and visual acuity Methods: Prospective case series. One hundred and twenty cases of non-ischemic non-tractional CSME with macular thickness more than 400 microns as defined by OCT were managed by...

Read More

Micropulsed 577 nm Laser Stimulation for DME

http://www.dailymotion.com/video/xueopo Advantages: Laser stimulation seems to be effective, safer, non-tissue harmful and cost effective to treat diabetic macular edema. Methods: Eighty-eight eyes of 78 diabetic patients with DME were treated with yellow diode laser (577 nm) suited for micropulse treatment in macular area. ETDRS best corrected visual acuity, High definition optical coherence tomography to determine central macular...

Read More

Aflibercept (VEGF Trap Eye, Eylea) for Treatment of Diabetic Macular Edema

http://www.dailymotion.com/video/xudsd8 http://www.dailymotion.com/video/xuf2lx Advantages: Aflibercept (VEGF Trap Eye, Eylea) has a longer duration of action compared to ranibizumab (Lucentis). Methods: Randomized clinical trials. Effectiveness / Safety: In a phase II trial patients with diabetic macular edema gained 9.7 letters with aflibercept every 8 weeks and 13.1 letters with aflibercept every 4 weeks.  Phase III trials, VISTA and...

Read More

Treatment of Diabetic Macular Edema with Ranibizumab

http://www.dailymotion.com/video/xudsd8 http://www.dailymotion.com/video/xuf2lx Advantages: Intravitreal ranibizumab improves vision of patients with diabetic macular edema. Methods: Review of recent clinical trials such as DRCR.net. Effectiveness / Safety: DRCR trials showed that in patients with diabetic macular edema, intravitreal ranibizumab with prompt or deferred focal/grid laser had superior Visual Acuity outcome compared with...

Read More

ILM Peeling in Patients with Clinically Significant DME: Long-term Outcomes

http://www.dailymotion.com/video/xudqwm http://www.dailymotion.com/video/xudrqk Background: Diabetic macular edema (DME) is a frequent complication of diabetic retinopathy. It is characterized to increased vascular permeability, due to blood-retinal barriers breakdown. Since macular laser treatment has shown poor efficacy to diffuse edema, surgical option of therapy is discussed. Several studies have proven the efficacy of pars plana...

Read More

Does Vitreous Surgery for Diabetes Complications Have an Influence on the Course of Macular Edema in Long-term Follow-up?

http://www.dailymotion.com/video/xudqwm http://www.dailymotion.com/video/xudrqk Advantages: To evaluate the influence of vitreous surgery performed for vitreous hemorrhage and traction retinal detachment (macular edema excluded) as a complication of diabetic retinopathy with or without ILM peeling on macular edema formation. Additionally to evaluate long-term spectral domain optical coherence tomography (SD-OCT) follow- up of macular...

Read More

PPV in Management of Type 1 Non-tractional DME After Failure of all Therapies

http://www.dailymotion.com/video/xudqwm http://www.dailymotion.com/video/xudrqk Advantages: PPV is a useful method in management of non-tractional, non-ischemic resistant diffuse diabetic macular edema associated with type 1 DM Methods: Type 1 Diabetic macular edema (DME) is typically managed by thermal laser, intravitreal injections and systemic control. An entity of diffuse DME persists despite all therapies. We present 5 cases of...

Read More

Vitrectomy Outcome in Resistent Non-tractional Diffuse DME

http://www.dailymotion.com/video/xudqwm http://www.dailymotion.com/video/xudrqk Advantages: Diabetic diffuse macular edema not responding to repeated IV injctions of Anti-VEGF and/or Triamcinolone may benefit from vitrectomy and ILM peeling. Vitrectomy helps to remove factors and mediators that may play a role in production of macular edema and/or its no or poor response to IV injections. ILM peeling ensure complete relieve of traction and...

Read More

Vitrectomy Outcome in Traction Diffuse DME

http://www.dailymotion.com/video/xudqwm http://www.dailymotion.com/video/xudrqk Advantages: In eyes with diffuse diabetic macular edema and OCT evidence of tangential and/or anteroposterior traction, Vitrectomy techniques allow complete release of traction, restoration of normal or near normal retinal architecture, and functional improvement. Methods: 65 eyes with traction diabetic diffuse macular edema underwent 23 gauge vitrectomy. All...

Read More

Vitrectomy for DME – An Alternative to Anti-VEGF Therapy?

http://www.dailymotion.com/video/xudqwm http://www.dailymotion.com/video/xudrqk Advantages: Vitrectomy for diabetic macula edema (DME) is and was used as a second line treatment. Published studies about this therapy option report mainly about small numbers of patients and show heterogenous results. In these times, when ranibizumab starts to dominate the therapy of DME, we want to present the functional results of vitrectomy for DME in a...

Read More

DME: 15 Injections or 1 Surgery?

http://www.dailymotion.com/video/xudqwm http://www.dailymotion.com/video/xudrqk Advantages: The first author has operated on over 600 eyes with DME in the last two decades. Surgery is typically a one-time intervention, unlike intraocular injections. Methods: Complete vitrectomy with detachment of the triamcinolone-marked posterior hyaloid face. This is followed by removal of the internal limiting membrane (ILM), stained by Indocyanine...

Read More

High Systolic Blood Pressure is Related to Macular Edema in Diabetic Patients

http://www.dailymotion.com/video/xudq1s Advantages: Systolic blood pressure control might reduce macular edema in diabetic patients. Methods: Medical records of 378 patients who were hospitalized in Asan Medical Center from November 1st, 2007 to June 1st, 2011 were reviewed retrospectively. All the patients were diagnosed as non-proliferative diabetic retinopathy and were tested with Stratus optical coherence tomography (OCT) for macular...

Read More

Vitreoretinal Interface Abnormalities Associated with Diffuse DME: Diagnosis and Management

http://www.dailymotion.com/video/xudq1s Advantages: Diabetic diffuse macular edema may be associated with multiple vitreoretinal interface abnormalities as epimacular membranes, vitreomacular traction syndrome, lamellar macular hole and full thickness macular hole. Vitrectomy combined with ILM peeling is effective in dealing with interface disorders with encouraging anatomical and functional results. Methods: Vitrectomy combined with ILM...

Read More

Terminologic Confusion in DME

http://www.dailymotion.com/video/xudq1s Background: Genuine confusion in the terminology of diabetic macular edema (DME) classification has existed for a long time. Only the definitions: focal versus diffuse DME and clinically significant macular edema (CSME) have been available since the ETDRS study. This is a far from satisfactory way to define many types of DME in the era of spectral OCT. Methods: OCT records of all DME cases in a...

Read More

Design of a Comparative Study Anti-VEGF vs Surgery for DME

http://www.dailymotion.com/video/xudv5d We will present the study-design of our prospective randomized multi-center study that will start in autumn 2012. Anti-VEGF-therapy has developed to the standard care for diabetic macular edema.  Vitrectomy is an additional treatment option that is able to stabilize DME. The pharmacokinetic effect of a vitrectomy is an increased VEGF-clearance in the eye, but also a higher clearance of...

Read More

Multiple Therapeutical Approaches for the Same DME

http://www.dailymotion.com/video/xudv5d Advantages: Our approaches were directed all the time to the pathogenetic causes obtaining a good functional result and reducing in this way complications and secondary effects. We present a 52 years old patient (Diabetes type I for 40 years) managed by partial PRP before first seen in February 2009 with a huge retrohyaloidal macular hemorrhage in the RE (VA < 20/200). The right eye was managed by...

Read More

Comparative Study of Vitrectomy with ILM Peeling vs Anti-VEGF in DME

http://www.dailymotion.com/video/xudv5d Advantages: To compare anatomic and functional results of vitrectomy with internal limiting membrane (ILM) peeling and anti- VEGF (Avastin) injection for the course of diabetic macular edema. Methods: Comparative non- randomized study of 68 eyes, of patients with diabetic macular edema. 50 eyes were treated with repeated injections of anti- VEGF (Avastin), 18 eyes had undergone vitrectomy with ILM...

Read More

Severe PDR Surgical Strategy

http://www.dailymotion.com/video/xudueb Advantages: Management of severe proliferative diabetic retinopathy is one of the most difficult medical problems of the present time. Methods: We would like to present 10 patients between 25-60 in whom control of diabetes has been unsatisfactory.  Fundus examination, in all of cases showed the final stage of diabetic retinopathy with vitreous hemorrhage, persistent macular edema, new vascular...

Read More

Miniinvasive Vitrectomy as a Gold Standard for Severe PDR

http://www.dailymotion.com/video/xudueb Advantages: To examine whether 25 gauge vitrectomy might be a good approach for the treatment of severe proliferative diabetic retinopathy (PDR) and macular edema. Methods: 11 patients with severe PDR and macular edema were randomized to either 23 or 25 gauge vitrectomy. The 25 gauge vitrectomy was performed with bimanual technique, 27 gauge chandelier illumination, Tano diamond dusted scraper. 5...

Read More

Clinical Outcomes of Intravitreal Bevacizumab Combined with Laser Photocoagulation as Primary Treatment of DME

Purpose: To know the clinical outcomes of intravitreal bevacizumab with laser photocoagulation as primary treatment in the diabetic macular edema. Methods: Patients who diagnosed with DME without vitreomacular traction and not underwent any other treatment were choosen to receive an intravitreal bevacizumab injection alone in 30 eyes and an intravitreal bevacizumab injection with laser photocoagulation in 31 eyes. We compared both groups....

Read More

Intravitreal Ranibizumab Combined with Selective Laser Coagulation of Pigment Epithelium for Cystoid DME

Advantages: Selective laser coagulation of pigment epithelium (SLCPE) is effective laser procedure for treatment diffuse and focal diabetic macular edema with minimal damage of retina, but cystoid macular edema (CDME) is very torpid to different treatment modalities, and the majority of authors prefer grid laser for its treatment. We suggested that previous intravitreal ranibizumab (0.5 mg) will create conditions for effective SLCPE in...

Read More

Determination of Ischemic Diabetic Maculopathy According to SOCT Data

Advantages: To develop the coefficient of ischemia in order to characterize pathological changes of retinal architectonics in microvascular occlusion in ischemic diabetic maculopathy according to non invasive method spectral optical coherence tomography in comparison to non ischemic retina without usage of fluorescent angiography. Methods: There were 25 eyes (18 patients) with diabetic macular ischemia to which along with general clinical...

Read More

Clinical Outcomes of Ultrahigh-speed 23 G with Duty Cycle Control System in the Treatment of PDR Complicated by Tractional RD

Clinical Outcomes of Ultrahigh-speed 23 G with Duty Cycle Control System in the Treatment of PDR Complicated by Tractional RD Jung Ho Lee Advantages:          Dealing with vitreous of detached retina with fibrovascular proliferation and traction complicated by proliferative diabetic retinopathy is a challenge. A higher cutter rate may minimize vitreous turbulence by allowing only small bits of vitreous to enter the port,...

Read More

Correlation Between Subfoveal Chroidal Thickness and Stage of Diabetic Retinopathy

Correlation Between Subfoveal Chroidal Thickness and Stage of Diabetic Retinopathy Jee Taek Kim Advantages: This study demonstrates differences in choroidal thickness according to DMR stage and DME type. Methods: Medical records of patients who were diagnosed with diabetic retinopathy between March and October 2011 were reviewed, retrospectively. Choroidal thickness was measured using enhanced-depth imaging optical coherence...

Read More

Effect of Doxium on High Sensitivity CRP and Endothelin-1 Serum Levels in Patients with Diabetic Retinopathy

Background: Diabetic retinopathy (DR) is a highly specific vascular complication of type 1 and type 2 diabetes mellitus. Calcium dobesilate (CD) or Doxium has been tested in the treatment of diabetic retinopathy showing a slowdown of the progression of the disease after long-term oral treatment, as a potent antioxidant. Endothelin-1 (ET-1) besides being a very potent vasoconstrictor, acts as a mitogen on the vascular smooth muscle and...

Read More

Can Serous Macular Detachment Help to Predict the Types of Maculopathy and the Severity of Retinopathy in Diabetic Patients?

Advantages: To search the importance of serous macular detachment (SMD) to predict the types of maculopathy and the severity of retinopathy in diabetic patients. Methods: 189 patients with retinopathy and clinically significant macular edema were included. Patients were grouped as SMD + (group I, n: 107) and SMD – (group II, n: 82) in optical coherence tomography (OCT). Fundus fluorescein angiographic (FA) findings were evaluated...

Read More

Assessment of Angiographic Findings of Diabetic Patients Who Underwent PPV for ERM or Taut Posterior Hyaloid

Advantages: To analyse the angiographic findings of diabetic patients who underwent pars plana vitrectomy for epimacular membrane or taut posterior hyaloid (TPH). Methods: Patients were grouped according to the presence of taut posterior hyaloid or ERM. Preoperative and postoperative angiographic, optical coherence tomography and visual acuity findings were compared in between groups. Arm to retinal circulation, arteriovenous transit...

Read More

PPV for Treatment of Diffuse Non Tractional DME

Purpose: To evaluate the anatomical and functional results of Pars Plana Vitrectomy (PPV), Intravitreal Triamcinolone (IVT) with or without Internal Limiting Membrane (ILM) peeling in the treatment of diffuse non tractional Diabetic Macular Edema (DME). Methods: A total of 11 eyes (9 patients), those underwent primary vitrectomy with or without ILM peeling, during the past 2 years, were included in this study. Best Corrected Visual...

Read More

Intravitreal Bevacizumab Injection Alone or Combined with Triamcinolone vs Macular Photocoagulation as Primary Treatment of DME

Purpose: To report the efficacy of a single intravitreal bevacizumab injection alone or in combination with intravitreal triamcinolone acetonide versus macular laser photocoagulation as primary treatment of diabetic macular edema. Methods:   72 eyes of 40 patients with clinically significant DME and no previous treatment were enrolled. The eyes were randomly assigned to one of three study arms: the intravitreal bevacizumab (IVB) group,...

Read More

Combined Cataract Surgery and Intravitreal Ranibizumab in Preventing Postoperative ME in Non-proliferative Diabetic Retinopathy

Purpose: To evaluate the role of intravitreal ranibizumab, injected at the time of cataract surgery on the progression of postoperative diabetic macula edema (PME) in non-proliferative diabetic retinopathy (NPDR). Setting: Multi-center, prospective randomized study. Methods: 80 Patients with NPDR and cataract were randomized to 40 only cataract surgery (Sham group) or 40-cataract surgery plus intraoperative ranibizumab injection...

Read More

Enhanced Depth Imaging OCT of the Choroid in DME

Enhanced Depth Imaging OCT of the Choroid in DME Francisco J. Ascaso Advantages: The choroidal thickness in patients with diabetic macular edema (DME) compared with that in healthy controls let us know the true role of choroids in DME. Methods: Twelve eyes of 9 patients with DME (65.5 ±8.4 years), 9 contralateral eyes without DME (60.2 ±13.7 years), and 186 eyes of 96 age-matched healthy volunteers (62.1 ±19.4 years) underwent enhanced...

Read More

Preoperative Intravitreal Bevacizumab in Diabetic Tractional Retinal Detachment

http://www.dailymotion.com/video/xn6rkh Satyen Deka, H Bhattacharjee, H Deka, M J Barman, R Saibum, S M Das (Guwahati, India) Advantages: Preoperative intravitreal bevacizumab in diabetic tractional retinal detachment (TRD) facilitates surgery, decreases the intraoperative bleeding and improves the visual acuity. Methods: In this non comparative interventional case series 10 eyes of 8 candidate diabetic TRD patients received 1.25 mg...

Read More

Techniques and Results of En Bloc Perfluorodissection for Tractional Retinal Detachment in Proliferative Diabetic Retinopathy

http://www.dailymotion.com/video/xn6rkh Shaheeda Mohamed*, Tsang Chi Wai (Hong Kong, China) Advantages: Retinal stability during hyaloid removal, better visualization of structures, assists dissection of fibrous membranes, facilitates endolaser of stabilised retina under tamponade, limits and confines blood. Methods: Prospective interventional case series of 13 eyes with tractional retinal detachment using en bloc perfluorocarbon dissection...

Read More

Four in One 25 G Vitreoretinal Surgery in Advanced Proliferative Diabetic Retinopathy Treatment

http://www.dailymotion.com/video/xn6rkh Kh.P. Takhchidi, S.S. Tillyakhodzhaev, A.A. Gorin, A.N. Bessarabov (Moscow, Russia) Surgical treatment of proliferative diabetic retinopathy (PDR) using 25-Ga technology requires the employment of special instruments for epiretinal membrane peeling and dissection of fibro-vascular proliferations – endovitreal spatula, forceps and scissors, but this technique has a lot of disadvantages. The...

Read More

Analgesic Effect of Topical Sodium Diclofenac During Retinal Photocoagulation for Diabetic Retinopathy; A Randomized Double-masked Placebo-controlled Crossover Clinical Trial

Alireza Ramezani, Morteza Entezari, Mohammad Mehdi Shahbazi, Yosef Semnani, Zhaleh Rajavi, Hossein Mohammad Rabie, Mehdi Yaseri (Tehran, Iran) Advantages: To evaluate the analgesic effect of topical sodium diclofenac 0.1% during retinal laser photocoagulation for diabetic retinopathy. Methods: In a randomized placebo-controlled intraindividual two-period crossover clinical trial, patients with diabetic retinopathy candidate for peripheral...

Read More

Glycemic Control and Macular Thickness in Diabetic Patients

Angela VP Loo, YH Yew, S Menon (Kuala Lumpur, Malaysia) Purpose: To measure macular thickness and volume in diabetic patients with High Definition Optical Coherence Tomography (HD-OCT) and to assess their relationship with the respective glycosylated hemoglobin level (HbA1c). Methods: This was a cross sectional, observational study where 165 eyes in 165 diabetic patients with increased macular thickness regardless of diabetic retinopathy...

Read More

The Dependence of Post-operative Visual Acuity on the Pre-operative State of Patients Operated for Complicated Diabetic Retinopathy

M. Zavorkova, L. Prochazkova, T. Benda (Usti nad Labem, Czech Republic) Advantages: Pars plana vitrectomy (PPV) helped us to resolve complications of diabetic retinopathy (DR) including tractional retinal detachment. Methods: Authors report the results of surgical interventions, performed between 2004-2009 to handle various complications of DR at the Department of Ophthalmology, Masaryk Hospital in Ústi nad Labem. PPV was performed in 106...

Read More

Micropulse Contiguous Grid Laser in Eyes with Diffuse Macular Edema Due to Diabetic Retinopathy

SH Sinclair (Drexel Univ School Med), B Parvus (Pennsylvania College of Osteopathic Medicine), L Lofdahl (Salus University), P Presti (Georgia Institute of Technology, Atlanta) Objective: To investigate micropulse contiguous grid laser in the treatment of eyes with diffuse diabetic macular edema (DDME) involving the fovea, resistant to prior treatment and second, to correlate OCT findings with central discriminant visual fields...

Read More

Article – Vitrectomy In Diabetic Retinopathy

Vitrectomy In Diabetic Retinopathy Hospital Geral de Santo António. Porto, Portugal Vitrectomy In Diabetic Retinopathy Ferreira N, Pessoa B, Macedo M, Queirós P, Meireles A Hospital Geral de Santo António. Porto, Portugal Background Diabetic retinopathy is a vascular retinal disease. Prolonged hyperglycaemia in diabetes can result in increased permeability and progressive occlusion of retinal vessels. These alterations may lead...

Read More

Congress – Optical Coherence Tomography as a Screening Method for Diabetic Macular Edema

SYMPOSIUM:MACULOPATHIES Moderator: Ferenc Kuhn Monday, June 20, 2005 Optical coherence tomography (OCT) as a screening method for diabetic macular edema Author: M. Sydorova, R. Skripnik Abstract Purpose: This study aimed to reveal early macular thickening using optical coherence tomography (OCT) measurements in diabetic patients. Methods: We investigated 15 eyes from 8 patients with diabetes but no ophthalmoscopic evidence of...

Read More

Surgical Removal and Analysis of Subfoveal Hard Exudate in Diabetic Retinopathy

http://www.evrs.eu/medias/2010/congress/Non-Proliferative-Diabetic-Maculopathies.flv Oh Kwon, Yongsung You (Seoul, South Korea) Purpose: To study the effect of surgical removal and the lipid composition of subfoveal hard exudates in diabetic retinopathy. Material and Methods: Retrospective study was done in consecutive 7 case series with dense subfoveal large hard exudates (> 1 DA) in diabetic retinopathy, which were surgically...

Read More

Vitrectomy for Tractional Diabetic Macular Edema

http://www.evrs.eu/medias/2010/congress/Non-Proliferative-Diabetic-Maculopathies.flv Hassan Mortada (Cairo, Egypt) Advantages: PPV, with or without ILM peeling relieves traction at the vitreoretinal interface, improves trans-vitreal oxygenation of the retina and removes growth factor reservoir in the premacular hyaloid. Methods: 46 eyes with tractional diffuse diabetic macular edema underwent PPV: 12 eyes with taut adherent posterior...

Read More

Individualized Therapy in Diabetic Maculopathy

http://www.evrs.eu/medias/2010/congress/Non-Proliferative-Diabetic-Maculopathies.flv Ivan Fiser, Martina Rubesova (Prague, Czech Republic) Advantages: We consider diabetic macular edema a very individual disease, which cannot be treated according to a single template. No doubt that in focal edema the direct laser coagulation of leaking MA brings the best effect. Diffuse edema is more questionable; grid laser is controversial or even...

Read More

Pars Plana Vitrectomy with Removal of Internal Limiting Membrane in the Treatment of Diffuse Non Tractional Diabetic Macular Edema

http://www.evrs.eu/medias/2010/congress/Non-Proliferative-Diabetic-Maculopathies.flv Jean-Paul Berrod, P. Genin Perriguey (Nancy, France) Advantages: Photocoagulation is currently the most recommended therapy however, the prognosis after laser treatment for diffuse edema was worse than focal edema. Pars plana vitrectomy with ILM peeling appears to be beneficial in eyes with diffuse non-tractional diabetic macular edema, and its...

Read More

Results of Vitrectomy with Internal Limiting Membrane Peeling in Treatment of Patients with a Diabetic Traction Macular Edema

http://www.evrs.eu/medias/2010/congress/Non-Proliferative-Diabetic-Maculopathies.flv Nikolai N. Umanets, Zoya A. Rozanova (Odessa, Ukraine) Advantages: In cases of unsuccessful treatment of diabetic macular edema by laser or intravitreal injections of antiangiogenic factors or corticosteroids frequently we can find out posterior hyaloid or internal limiting membrane traction. In this connection to patients with a diabetic traction macular...

Read More

Experience of Intravitreal Erythropoietin Therapy for Eyes with Chronic and Progressive Diabetic Macular Edema

http://www.evrs.eu/medias/2010/congress/Non-Proliferative-Diabetic-Maculopathies.flv Stephen H. Sinclair (Dept. of Ophthalmology, Drexel University College of Medicine, Philadelphia, PA, USA), 1, Weiye Li (Dept. of Ophthalmology, Drexel University College of Medicine, Philadelphia, PA, USA / Laboratory of Clinical Visual Sciences, Institute of Health Sciences (IHS), Shanghai Institutes for Biological Sciences (SIBS), Chinese Academy of...

Read More

Comparison of Grid Laser, Intravitreal Triamcinolone, and Intravitreal Bevacizumab for the Treatment of Diffuse Diabetic Macular Edema

http://www.evrs.eu/medias/2010/congress/Non-Proliferative-Diabetic-Maculopathies.flv Gungor Sobaci, Cuneyt Erdurman, A. Hakan Durukan (Ankara, Turkey) Purpose: Controversy exists in the literature regarding the most appropriate method of treatment in diabetic macular edema. We aimed to find out the current best care for selected group of patients who had untreated, acute, and diffuse diabetic macular edema. Methods: Patients with acute DDME...

Read More

Fundus Autofluorescence in Diabetic Macular Edema: Subthreshold Micropulse Diode Laser vs Modified Early Treatment Diabetic Retinopathy Study Laser Photocoagulation

http://www.evrs.eu/medias/2010/congress/Non-Proliferative-Diabetic-Maculopathies.flv Evangelia Papavasileiou, S. Sivaprasad, S. Liazos, R. Mathew, I. Bisbas (London, UK) Advantages: The advantages of this study were to evaluate and compare fundus autofluorescence (FAF) after subthreshold micropulse diode laser versus modified Early Treatment Diabetic Retinopathy Study photocoagulation for clinically significant diabetic macular...

Read More

Focal Laser Treatment for Diabetic Macular Edema Using a Retinal Navigated Laser (NAVILAS)

http://www.evrs.eu/medias/2010/congress/Non-Proliferative-Diabetic-Maculopathies.flv Marcus Kernt, Armin Wolf, Efstathios Vounotrypidis, Michael W. Ulbig, Anselm Kampik, Aljoscha S. Neubauer (Munich, Germany) Purpose: To investigate the applied accuracy of a navigating laser photo-coagulator when treating clinically significant macular edema. The NAVILAS® is featured with retinal movement tracking and a precise visualization of targeted...

Read More

Intravitreal Injections of Triamcinolone vs Bevacizumab vs Sham Treatment during Phacoemulsification on Diabetic Macular Edema

http://www.evrs.eu/medias/2010/congress/Non-Proliferative-Diabetic-Maculopathies.flv Siamak Moradian, Amir Faramarz, Qiumars Heidari, Masoud Salehipoor, Mohammad Mohammadzadeh (Tehran, Iran) Advantages: To compare the results of IVT vs IVB vs sham injections at the end of phacoemulsification (PE) on diabetic macular edema (DME). Methods: In a RCT 88 diabetic patients with at least moderate NPDR were undergone one of the 3 injections, IVT...

Read More

Intravitreal Anti-VEGF Therapy (Bevacizumab) in Diabetic Macular Edema

http://www.evrs.eu/medias/2010/congress/Non-Proliferative-Diabetic-Maculopathies.flv Veronika Aslanova, Nikolai Umanets (Odessa, Ukraine) Advantages: Intravitreal bevacizumab injection lead to a significant visual improvement in patients with diabetic macular edema soon after procedure. Methods: 28 patients (36 eyes), (24 females, 4 males), mean age 62 y/o, with diabetic macular edema were consecutively enrolled in the noncomparative...

Read More

Comparison Wide Fundus Photography Using the Optomap P200C and 7 Standard ETDRS Fundus Photography in the Screening of Diabetic Retinopathy

Joo Yong Lee, Sung Jae Yang, Soo Geun Joe, June-Gone Kim, Young Hee Yoon (Seoul, South Korea) Advantages: The purpose of the study was to compare the wide fundus photography taken by the Optomap P200C and 7 standard early treatment diabetic retinopathy (ETDRS) fundus photographs for diabetic retinopathy screening. Methods: In 25 diabetic patients (50 eyes), one 200-degree wide field fundus photography without dilation by Optomap p200C and...

Read More

Unwanted Effects Following Intravitreal Bevacizumab (Avastin) as an Adjuvant to PRP in Proliferative Diabetic Retinopathy

Dae Young Lee, Suk Ho Moon, Sang Woong Moon, Dong Heun Nam, Hae Jung Paik (Incheon, South Korea) Advantages: To report the unwanted effects after intravitreal Bevacizumab injection as an adjunctive treatment to Panretinal Photocoagulation (PRP) for high-risk Proliferative Diabetic Retinopathy (PDR). Methods: The study was a retrospective chart review of patients with unwanted adverse effects (TRD, vitreous hemorrhage) following...

Read More

The Short Term Efficacy of Intravitreal Ranibizumab in the Treatment of Diabetic Macular Edema

Kyu Seo Kim, Dong Hyun Jee, Sang Hee Doh, Jae Hyung Park (Suwon, South Korea) Advantages: To evaluate the short-term effect of an intravitreal injection of ranibizumab in the treatment of diabetic macular edema. Methods: We retrospectively evaluated 18 eyes of 18 patients who underwent intravitreal ranibizumab injection for the treatment of diabetic macular edema between March 1 and November 30, 2009. Complete ophthalmic examinations...

Read More

Non-Mydriatic Fundus Photography for the Screening of Diabetic Patients for Retinal Pathology

David Hauser, Giora Treister, Yoel Greenwald (Ashkelon, Israel) Advantages: A telemedicine project using digital non-mydriatic retinal photography can be an effective screening tool for ophthalmic pathology. Methods: This cross-sectional study included diabetic patients referred by their primary care physician to undergo retinal testing. A single technician using a Topcon TRC-NW300 retinal camera between September 2008 and March 2010...

Read More

Evaluation of Phacoemulsification, Vitrectomy, IOL Implantation for Complications of Proliferative Diabetic Retinopathy

Hussein K. Elgendy (Jeddah, Saudi Arabia) Advantages: To evaluate the effectiveness and safety of combined phacoemulsification, pars plana vitrectomy (PPV), and intraocular lens (IOL) implantation in complicated proliferative diabetic retinopathy (PDR) patients. Methods: The results of combined operation of phacoemulsification pars plana vitrectomy (PPV) and foldable IOL implantation in 38 eyes of 38 patients with cataract and...

Read More

Comparison of Intravitreal Triamcinolone and Combined Triamcinolone-Bevacizumab Injection as Adjunctive Treatment to Grid Laser Photocoagulation for Diffuse Diabetic Macular Edema

Osman Çekiç, M. Selim Kocabora, Nilay Kandemir (Istanbul, Turkey) Advantages: To assess the effectiveness of intravitreal triamcinolone and combined triamcinolone-bevacizumab injection as adjunctive treatment to grid laser for diffuse diabetic macular edema. Methods: Sixty-nine eyes of 69 patients (29 male, 40 female) with diffuse diabetic macular edema were intravitreally injected either with 4mg/0.1ml triamcinolone (n = 29) or...

Read More

The Combination of Intravitreal Bevacizumab and Phacoemulsification Surgery in Patients with Cataract and Coexisting Diabetic Macular Edema

Ozgür Bilen, Kubilhan Elmas, Ali Altýnsoy (Ankara, Turkey) Purpose: The aim of this study was to assess the efficacy of phacoemulsification combined with intravitreal bevacizumab injection in diabetics with clinically significant macular edema (CSME) and cataract. Methods: This retrospective study included diabetic patients with cataract and CSME who underwent phacoemulsification and intraocular lens implantation with a 1,25-mg...

Read More

Why Intravitreal Avastin Injections are Useful before Pars Plana Vitrectomy in Diabetic Patient and When

Nabil Abdulghani Taresh Ali, Amin A. Okbah, Ahmed Labib, Basma Alrefaei (Sanaa, Yemen) Purpose: To detect the role of intravitreal Avastin injection before pars plana vitrectomy in diabetic patients and when doing operation after Avastin injection. Material and methods: 40 patients with advanced proliferative diabetic retinopathy with tractional retinal detachment (TRD) and vitreous hemorrhage. Best corrected visual acuity Slit lamp...

Read More

Transconjunctival Sutureless Vitrectomy for the Treatment of Vitreoretinal Complications in Diabetic Patients

Yusuf Akar, K. Cemil Apaydin, Mustafa Unal, Erkan Coban, Koray Demir, Koray Ahat, Meryem Guler, Pinar Tavas (Antalya, Turkey) Advantages: 23 Gauge transconjunctival sutureless vitrectomy appears to be a feasible option in treating vitreoretinal complications in diabetic patients, with the potential benefit of reducing postoperative ocular irritation. Methods: Seventy four eyes of 76 consecutive patients with diabetes mellitus who...

Read More

Vitrectomy with ILM Peeling in Persistent Diabetic Macular Edema

http://www.evrs.eu/medias/2010/videos/AshrafRadwan_VP6_768K.flv Ashraf Radwan, Ahmed Ibrahim (Jeddah, Saudi Arabia) Advantages: Vitrectomy with internal limiting membrane peeling edema help in improvement of persistent diabetic macular and improvement of visual acuity. Methods: Pars plana vitrectomy (20 Gauge) with removal of posterior hyaloid then injection of Brilliant Peel dye then ILM peeling. Effectiveness / Safety: Vitrectomy with...

Read More

Intravitreal Avastin Prior to Vitrectomy and Removal of Advanced Diabetic Tractional Membrane

http://www.evrs.eu/medias/2010/videos/AhmedIbrahim_1_VP6_768K.flv Ahmed Ibrahim (Jeddah, Saudi Arabia) Advantages: Intravitreal Avastin Injection one Week prior to Vitrectomy and Removal of Advanced Diabetic Tractional Membrane Make It Easy to Sissect, Peel and Bleeding is less. Methods: Intravitreal Avastin injection done. And after one week 20 Gage pars plana vitrectomy performed with use of 23 Gauge curved needle and scissors to peel,...

Read More

Pars Plana Vitrectomy and Epiretinal Membrane Peeling in Cases of Vitreous Hemorrhage with Tractional Retinal Detachment

http://www.evrs.eu/medias/2010/videos/MohamedElDeeb_1_VP6_768K.flv Mohamed El-Deeb (Cairo, Egypt) Advantages: This video shows the classic surgical steps for management of cases of diabetic vitreous hemorrhage with tractional retinal detachment. If the surgeon masters these steps, he will achieve very satisfactory surgical results. Methods: This video shows the classic surgical steps for management of vitreous hemorrhage with tractional...

Read More

25 Gauge Vitrectomy – An Effective Method for Sutureless Diabetic Vitrectomy

http://www.evrs.eu/medias/2010/videos/AbhijitChattopadhyay_VP6_768K.flv Abhijit Chattopadhyay, Chirag Bhatt, Soumen Mandal, Shubhankarsri Paul (Kolkata, India) Advantages: 25 Gauge sutureless methods allow early ambulation and quick recovery. This system also helps in better maintenance of intra-ocular pressure thus reducing the intra-operative bleeding. The hospital staying time also got reduced remarkably. The lid swelling and...

Read More

Bimanual Vitrectomy – A Safer Way to Manage Severe Proliferative Diabetic Retinopathy

http://www.evrs.eu/medias/2010/videos/ChiragBhatt_1_VP6_768K.flv Chirag Bhatt, Aniruddha Maiti, R. C. Paul, P. K. Chatterjee, Aditya Kelkat, Abhijit Chattopadhyay (Kolkata, India) Advantages: Diabetic retinopathy is one of the leading causes of blindness in the world. Vitrectomy may not only remove vitreous hemorrhage but also prevent or relieve traction on the retina from contraction of the fibrovascular membranes that characterize severe...

Read More

23 Gauge for Proliferative Diabetic Retinopathy: It Has to Be!

http://www.evrs.eu/medias/2010/videos/EnricoBertelli_VP6_768K.flv Enrico Bertelli, Paolo Pelanda (Bolzano, Italy) Advantages: 23 Gauge transconjunctival vitrectomy is a minimally invasive vitreoretinal technique that offers the advantages of sutureless surgery combined with the benefits of a sturdy instrumentation, this latter feature making it potentially suitable for a large number of indications. Methods: The video highlights the ample...

Read More

25 Gauge Vitrectomy Techniques for Proliferative Diabetic Retinopathy

http://www.evrs.eu/medias/2010/videos/FlorianBalta_VP6_768K.flv Florian Balta (Bucharest, Romania) Advantages: Reduction of the surgically induced trauma to the ocular tissue and reduction of the operative time. Methods: Removal of the membranes in proliferative diabetic retinopathy (PDR) using 25 Gauge instruments: the vitreous cutter is used at 5000 cuts / min (Constellation Alcon) either alone or combined with an intraocular forceps in...

Read More

Proliferative Diabetic Retinopathy: Principles and Techniques of Vitreoretinal Surgery

Hassan Mortada (Cairo, Egypt) Introduction: Diabetes mellitus is the most common cause of proliferative vascular retinopathy which also includes retinal venous occlusive disease, sickle cell retinopathy and retinopathy of prematurity. The underlying abnormality in these disorders is retinal ischemia, which may ultimately lead to the formation and contraction of proliferative fibrovascular membranes with subsequent vitreous hemorrhage and...

Read More

Vitrectomy with ILM Peeling vs without ILM Peeling for Proliferative Diabetic Retinopathy

http://www.evrs.eu/medias/2010/congress/Proliferative-Diabetic-Retinopathy.flv Dominik Odrobina, Sławomir Cisiecki, Krzysztof Dzięgielewski, Zbigniew Pikulski, Janusz Michalewski, Zofia Michalewska, Jerzy Nawrocki (Lodz, Poland) Advantages: To analyze the effect of internal limiting membrane (ILM) peeling on the anatomical and functional outcomes in patients undergoing vitrectomy for proliferative diabetic retinopathy with vitreous...

Read More

Results of Combined Phacoemulsification, IOL Implantation and 23 Gauge Vitrectomy for Complications of Proliferative Diabetic Retinopathy

http://www.evrs.eu/medias/2010/congress/Proliferative-Diabetic-Retinopathy.flv Mushfig Karimov (Baku, Azerbaijan) Purpose: Data of 12 patients (12 eyes) with diabetes mellitus, who underwent phacoemulsification, IOL implantation and 23 Gauge pars plana vitrectomy for complications of proliferative diabetic retinopathy were analyzed. Follow-up ranged from 3 to 9 months. Results: Overall, visual acuity improved in 11 of 12 eyes (91.7%), in 9...

Read More

25 Gauge Vitrectomy as the Gold Standard for Severe PDR

http://www.evrs.eu/medias/2010/congress/Proliferative-Diabetic-Retinopathy.flv Cesare Forlini (Ravenna, Italy), Matteo Forlini (Modena, Italy), Adriana Bratu (Ravenna, Italy), Paolo Rossini (Ravenna, Italy) Advantages: To examine whether 25 Gauge vitrectomy might be a good approach for treatment of severe proliferative diabetic retinopathy (PDR) and macular edema. Methods: 31 patients with severe PDR and macular edema were randomized to...

Read More

Vitrector vs Bimanual Technique for the Surgical Treatment of Proliferative Diabetic Retinopathy: Is the New Always the Best?

http://www.evrs.eu/medias/2010/congress/Proliferative-Diabetic-Retinopathy.flv Barbara Parolini, Grazia Pertile (Verona, Italy) The new gauges and vitrectomy machines are leading to a wider use of the vitrectomy probe for various and finer surgical steps. The 23, 25, and 27 Gauges seem to be able to substitute the scissors for peeling and cutting membranes in PVR and PDR. However this talk is designed to present some surgical scenarios of...

Read More

Microincision Vitrectomy Surgery (MIVS) to Treat Complications of Diabetic Retinopathy

http://www.evrs.eu/medias/2010/congress/Proliferative-Diabetic-Retinopathy.flv Vito Primavera, Isabella Turco, Francesco Prascina, Nicola Delle Noci (Foggia, Italy) Advantages: To compare the effectiveness and safety of 25+  (Alcon, CONSTELLATION® Vision System) and 23 Gauge (Alcon, Accurus® Surgical System) MIVS in the management of vitreoretinal complications in patients with diabetic retinopathy. Methods: 34 consecutive patients...

Read More

The Advantages of 20 Gauge Vitrectomy in Advanced Proliferative Diabetic Retinal Detachments

http://www.evrs.eu/medias/2010/congress/Proliferative-Diabetic-Retinopathy.flv Theodoros Potamitis, Yianna Antoniou (Limassol, Cyprus) Advantages: Although 23 Gauge and 25 Gauge vitrectomy systems have recently revolutionized our surgical techniques in many retinal pathologies, in our most complicated cases of tractional retinal detachments the advantages conferred by the use of 20 Gauge instruments outweighs the benefits of smaller gage...

Read More

New Vitrectomy Technique in PDR

http://www.evrs.eu/medias/2010/congress/Proliferative-Diabetic-Retinopathy.flv Carl Claes (Antwerp, Belgium) Advantages: A new technique is presented to perform vitrectomy under stable intra-ocular conditions, within 2mmHg variation. This is very useful in cases with neovascularization and a high bleeding tendency intra-operatively, as in proliferative diabetic retinopathy. Methods: New, one step valved 23 Gauge trocars are used in...

Read More

24 Hours Preoperative Intravitreal Bevacizumab (Avastin) for Repair of Retinal Detachment in Eyes with Active Proliferative Diabetic Retinopathy

http://www.evrs.eu/medias/2010/congress/Proliferative-Diabetic-Retinopathy.flv Hassan Mortada (Cairo, Egypt) Advantages: Preoperative intravitreal Avastin injection produces significant reduction of retinal neovascularization. This dramatic effect may be related to its activity against all isoforms of VEGF. However, intravitreal Avastin injection is not without complications. It may lead to contraction of the fibrovascular tissue with...

Read More

Efficacy of Intravitreal Triamcinolone Acetonide Injection in Treating Refractory Proliferative Diabetic Retinopathy

http://www.evrs.eu/medias/2010/congress/Proliferative-Diabetic-Retinopathy.flv Arwa Azmeh, Judi Abdin (Damascus, Syria) Advantages: To evaluate the efficacy of intravitreal triamcinolone acetonide injection (IVT) in causing regression of new vessels activity in proliferative diabetic retinopathy (PDR) refractory to pan retinal photocoagulation (PRP). Methods: 11 eyes of 10 patients with type 2 diabetes and active PDR refractory to PRP...

Read More

Efficacy of Intravitreal Bevacizumab in Treating Refractory Proliferative Diabetic Retinopathy

http://www.evrs.eu/medias/2010/congress/Proliferative-Diabetic-Retinopathy.flv Arwa Azmeh, Wafi Maihoub (Damascus, Syria) Advantages: To evaluate the efficacy of intravitreal Bevacizumab  (IVB) injection in causing regression of new vessels activity in patients with proliferative diabetic retinopathy (PDR) refractory to pan retinal photocoagulation (PRP). Methods: 32 eyes of 23 patients with type 2 diabetes and active PDR refractory to...

Read More

Laser Coagulation in Proliferative Diabetic Retinopathy

http://www.evrs.eu/medias/2010/congress/Proliferative-Diabetic-Retinopathy.flv Ivan Fiser (Prague, Czech Republic) Advantages: We should never stop warning against too extensive and destructive laser treatment in PDR. Modern lasers enable an effective coagulation of the RPE, still favoring the neuroretina. We have a suspicion that too extensive treatment with heavy burns can even cause an inflammation that stimulates the VEGF and the...

Read More

Is Surgery of Late Complex Proliferative Diabetic Retinopathy Always Justified?

http://www.evrs.eu/medias/2010/congress/Proliferative-Diabetic-Retinopathy.flv Majed Bakjaji, Abdelouahed Amraoui, Adil Mchachi (Casablanca, Morocco) Advantages: Reduced risk of development of neovascular glaucoma, recurrent vitreous hemorrhage, tractional retinal detachment, combined tractional rhegmatogenous retinal detachment, and severe fibrovascular proliferation, improved visual outcome. Methods: Two groups of patients with late...

Read More

Recurrent Diabetic Vitreous Hemorrhage: The Best Time for Anti-VEGF Injection to Avoid Recurrent Postoperative Hemorrhages

http://www.evrs.eu/medias/2010/congress/Proliferative-Diabetic-Retinopathy.flv Mario R. Romano, C. Costagliola, P. Vinciguerra (Milan, Italy) Advantages: Intravitreal Bevacizumab is efficacious as pre-operative adjuvant treatment rather than intra-operative, for the management of recurrent postoperative hemorrhages in patients with advanced proliferative diabetic retinopathy (PDR). Methods: The patients were divided in two groups: Group A...

Read More

The System of Dynamic Follow-Up and Treatment Tactics of Late Post-Vitrectomy Vitreous Hemorrhages in Diabetic Patients

http://www.evrs.eu/medias/2010/congress/Proliferative-Diabetic-Retinopathy.flv Sergey V. Nosov, Victor N. Kazaikin (Ekaterinburg, Russia) Advantages: The developed system of dynamic follow-up and treatment tactics including choice of additional operation techniques in patients with late post-vitrectomy diabetic vitreous hemorrhages (PVDVH) takes into consideration the character of sclerotomies healing and course of diabetes. Methods: The...

Read More

Treatment of Diffuse Diabetic Macular Edema: Bevacizumab versus Multifocal Photocoagulation

http://www.evrs.eu/medias/2009/congress/Diabetes.flv Authors: Vladimir Poposki, Daniel  Vilaplana, Daniela Poposka, Isaac Alarcón, O.  Marínez-Giralt, M. Castilla , Barcelona, Spain Advantages: To evaluate the efficacy of Bevacizumab regarding photocoagulation in the treatment of diffuse diabetic macular edema (EMDD). Methods: In a prospective and randomised study, 25 eyes of 15 patients with mean age of 70 years were analysed. Complete...

Read More

Comparison of Effect of Cataract Surgery with Bevacizumab Alone and Combined with Intravitreal Triamcinolone on Progression of Diabetic Retinopathy

Authors: Elmas Kubilhan, Bilen Özgür, Arsen Akýncý, Ersel Özkýlýç, Ali Altýnsoy, Ankara, Turkey Advantages / Purpose: To study the effect of Cataract Surgery with Bevacizumab alone and Combined with Intravitreal triamcinolone Injection on Progression of Diabetic Retinopathy. Setting: Kudret Eye Hospital, Ankara. Methods: Cataract surgery with phacoemulsification was performed in 52 eyes of 44 patients who had diabetic retinopathy....

Read More

What about DME? We Choose a Different Way Combined Medical Approach

Authors: José Juan Escobar Barranco, Begoña Pina Marín, Barcelona, Spain Advantages: The main cause of blindness in type II diabetic patients is macular edema. We suggest a combined medical approach from the beginning of diabetic multifocal macular edema, which yields a visual acuity (VA) gain and a stabilization of the symptomatology with a good profile of safety. Methods: We show 31 eyes of 18 diabetic II patients with very poor...

Read More

Chronic and Hemorragic Retinal Detachment im Proliferant Diabetic Retinopathy

http://www.evrs.eu/medias/2009/videos/DanielVilaplana_2_VP6_768K.flv Authors: Daniel Vilaplana, Vladimir Poposki, Isaac Alarcon, D. Martin, M. Castilla, Barcelona, Spain Advantages: A 65-year-old homeless man with hand movements vision in his left eye for a long period (the patient was unaware of this). He has been recently diagnosed with advanced diabetes mellitus. He suffered from high-risk proliferation with a chronic and haemorrhagic...

Read More

Pars Plana vitrectomy Results in Proliferative Diabetic Retinopathy

Authors: Zeliha Yazar, Nil Irem Ucgun, Mehmet Onen, Turan Kayik, Ankara, Turkey Advantages / Purpose: The evaluation of pars plana vitrectomy (PPV) surgery results on proliferative diabetic retinopathy (PDR) cases. Methods: One hundred and sixteen eyes of 90 PDR cases were examined retrospectively. Their age was between 20 and 83; 51 were females (56%) and 39 were males (44%). Their ocular features, pre and postoperative visual acuity and...

Read More

Vitreous Cavity Hemorrhages and Fibrovascular Ingrowth after Primary 25 Gauge Vitrectomy in Diabetic

http://www.evrs.eu/medias/2009/congress/Proliferative-Diabetic-Retinopathy.flv Authors: Sergey V. Nosov, A.N. Varaksin, Yekaterinburg, Russia Advantages: Multiple investigators reveal fibrovascular ingrowth (FVIG) and anterior hyaloidal fibrovascular proliferation (AHFVP) at UBM of former sclerotomy sites after primary vitrectomy in diabetic patients. It is considered that FVIG and AHFVP are the reason of postvitrectomy diabetic vitreous...

Read More

New Generation 25 Gauge Vitrectomy for Proliferative Diabetic Retinopathy

http://www.evrs.eu/medias/2009/congress/Proliferative-Diabetic-Retinopathy.flv Authors: Vito Primavera, Isabella Turco, Giuseppe Schiena, Francesco Prascina, Nicola Delle Noci, Foggia, Italy Advantages: To compare the feasibility and efficacy between bimanual membrane peeling technique vitrectomy (group 1) and new generation 25 gauge vitrectomy system (group 2) for treating traction retinal detachment (TRD) secondary to severe...

Read More

Anti-VEGF (Bevacizumab) Before Vitrectomy in Severe Proliferative Diabetic Retinopathy

http://www.evrs.eu/medias/2009/congress/Proliferative-Diabetic-Retinopathy.flv Authors: Stanislav Rodin, Veronika Aslanova, Nikolai Umanetz, Odessa, Ukraine Advantages: Intravitreal injection of bevacizumab before VE for severe PDR reduced hemorrhage risk and allowed to perform more effective surgery with complete and safe neovascularized ERM removal. Methods: The results of treatment of 17 patients (18 eyes) (20-67 y/o, 7 males, 10...

Read More

Avastin in Complicated Diabetic Retinal Detachments

http://www.evrs.eu/medias/2009/congress/Proliferative-Diabetic-Retinopathy.flv Author: Maria H. Berrocal, San Juan, Puerto Rico Advantages: Preoperative Avastin reduces intraoperative complications and surgical time in complex diabetic retinal detachments. Methods: In this prospective study, 48 eyes undergoing pars plana vitrectomy for tractional (Group 1) and combined tractional and rhegmatogenous (Group 2) retinal detachment secondary to...

Read More

The Results of 20 Gauge and 23 Gauge Vitrectomy Combined with Phacoemulsification after Intravitreal Bevacizumab Injection in Tractional Retinal Detachment with Proliferative Diabetic Reinopathy

http://www.evrs.eu/medias/2009/congress/Proliferative-Diabetic-Retinopathy.flv Author: Hulya Gungel, Istanbul, Turkey Advantages: To reduce intraoperative bleeding. Methods: Forty-nine patients with tractional retinal detachment were studied retrospectively. To 23 patients 20 G PPV, to 26 patients 23 G MIVS combined with phacoemulsification were applied. They had tractional retinal detachment with macular involvement, rhegmatogenous retinal...

Read More

ILM Peeling in DME

http://www.evrs.eu/medias/2009/congress/Diabetes.flv Author: Ivan Fiser, Prague, Czech Republic Advantages: The ILM peeling has a beneficial effect in DME in which laser treatment is ineffective (MA in FAZ, CME, diffuse DME). Methods: Forty eyes of 35 patients 17 male, 18 female, mean age 60.2 ± 14.8)were operated using the ILM peeling with the help of trypan blue. Effectiveness / Safety: Anatomical finding (foveal thickness, lipids)...

Read More
content top